Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 245 participants.

Also called NCT01215435

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 245 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01215435
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Iran (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01215435. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2013-11-25.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
biphasic insulin aspart 30
Intervention (Drug)
biphasic insulin aspart 30
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01215435
Content hash
26717377899f99197de5a836f7787f5505cf792ba20fc2ee56335fb72629b802